Please login to the form below

Wilmington Healthcare makes new senior appointment

Healthcare intelligence provider Wilmington Healthcare, which incorporates Binley’s, NHiS, Wellards and HSJ, has promoted a longstanding employee, Shelley Jessop, to the role of Account Director.

Shelley who has worked for Wilmington Healthcare brands since graduating from university 17 years ago, will be overseeing a number of key accounts and ensuring that the specialist teams meet their objectives.  

Shelley’s most recent post at Wilmington Healthcare was Business Development Director, responsible for all aspects of the sales cycle from identifying new opportunities to negotiating and closing deals.  

Prior to that, Shelley was a sales consultant for Wilmington Healthcare’s NHiS Insight team, which provides business intelligence and insight solutions to the pharma industry.
 

Other posts that Shelley has held for Wilmington Healthcare companies include Business Development Manager and Assistant Research Manager for Binley’s, which provides healthcare data and intelligence to pharma.
       

Gareth Thomas, Managing Director of Wilmington Healthcare, said: “Shelley has enjoyed a long and successful career with Wilmington Healthcare’s brands. I am very pleased to promote her to the role of account director. I know that she will continue to build on the strong relationships she has with her clients and be an extremely valuable asset to our expanding business.” 



                                                                                   Ends   

31st October 2017

Share

Company Details

Wilmington Healthcare

01268 495600

Contact Website

Address:
Beechwood House
2-3 Commercial Way
Christy Close
Southfields
Basildon
SS15 6EF
United Kingdom

Latest content on this profile

White paper helps industry navigate new NHS roadmap
New report shows how pharma can support the NHS in the Covid-19 recovery era
Wilmington Healthcare
Covid-19 drives change in long-term conditions management
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore how patients are being empowered to manage their conditions at home
Wilmington Healthcare
Covid-19: how is it impacting on the NHS Long-term Plan?
Oli Hudson and Paul Midgley, of Wilmington Healthcare, explain how coronavirus has expedited some parts of the plan but put others in jeopardy
Wilmington Healthcare
Covid-19: what could it mean for the diabetic population?
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it
Wilmington Healthcare
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve
Wilmington Healthcare
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond
Wilmington Healthcare